These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 9306726

  • 1. [Research and development of beraprost sodium, a new stable PGI2 analogue].
    Nishio S, Nagase H, Kanou K, Aoki S, Kanbayashi Y.
    Yakugaku Zasshi; 1997 Aug; 117(8):509-21. PubMed ID: 9306726
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue].
    Nishio S, Kurumatani H.
    Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):123-30. PubMed ID: 11233303
    [Abstract] [Full Text] [Related]

  • 3. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T, Murai T, Kanai T, Ogaki Y, Sanai K, Kanda H, Sato S, Kajikawa N, Umetsu T, Matsuura H.
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [Abstract] [Full Text] [Related]

  • 4. Effect of a prostaglandin I2 analogue, beraprost sodium, on burn-induced gastric mucosal injury in rats.
    Battal MN, Hata Y, Matsuka K, Ito O, Matsuda H, Yoshida Y, Kawazoe T, Nagao M.
    Burns; 1997 May; 23(3):232-7. PubMed ID: 9232284
    [Abstract] [Full Text] [Related]

  • 5. Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.
    Melian EB, Goa KL.
    Drugs; 2002 May; 62(1):107-33. PubMed ID: 11790158
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
    Matsumoto T, Iwasa K, Kyuragi R, Honma K, Guntani A, Ohmine T, Itoh H, Onohara T, Maehara Y.
    Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
    [Abstract] [Full Text] [Related]

  • 7. Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus.
    Kato H, Takashima T, Kishikawa H, Emura S, Ohmori K.
    Int J Clin Pharmacol Res; 1996 Apr; 16(4-5):99-102. PubMed ID: 9172007
    [Abstract] [Full Text] [Related]

  • 8. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
    Murata T, Sakaya S, Hoshino T, Umetsu T, Hirano T, Nishio S.
    Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
    [Abstract] [Full Text] [Related]

  • 9. Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats.
    Umetsu T, Murata T, Nishio S.
    Arzneimittelforschung; 1989 Jan; 39(1):68-73. PubMed ID: 2541730
    [Abstract] [Full Text] [Related]

  • 10. Effect of beraprost sodium (Procylin), a stable prostaglandin I2 analogue, on a dorsal skin flap model in rats.
    Alexandrou K, Hata Y, Matsuka K, Matsuda H.
    Scand J Plast Reconstr Surg Hand Surg; 1996 Mar; 30(1):17-22. PubMed ID: 8711437
    [Abstract] [Full Text] [Related]

  • 11. Beraprost sodium, a stable prostacyclin analogue, elicits dilation of isolated porcine retinal arterioles: roles of eNOS and potassium channels.
    Ono S, Nagaoka T, Omae T, Tanano I, Kamiya T, Otani S, Ishibazawa A, Yoshida A.
    Invest Ophthalmol Vis Sci; 2014 Jul 31; 55(9):5752-9. PubMed ID: 25082887
    [Abstract] [Full Text] [Related]

  • 12. The effects of beraprost Na, a stable prostacyclin analog, on animal models of stroke.
    Hirano T, Yamori Y, Kanai N, Umetsu T, Nishio S.
    Mol Chem Neuropathol; 1992 Aug 31; 17(1):91-102. PubMed ID: 1388452
    [Abstract] [Full Text] [Related]

  • 13. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects.
    Nony P, Ffrench P, Girard P, Delair S, Azoulay S, Girre JP, Dechavanne M, Boissel JP.
    Can J Physiol Pharmacol; 1996 Aug 31; 74(8):887-93. PubMed ID: 8960377
    [Abstract] [Full Text] [Related]

  • 14. The novel prostaglandin I2 mimetic ONO-1301 escapes desensitization in an antiplatelet effect due to its inhibitory action on thromboxane A2 synthesis in mice.
    Kashiwagi H, Yuhki K, Kojima F, Kumei S, Takahata O, Sakai Y, Narumiya S, Ushikubi F.
    J Pharmacol Exp Ther; 2015 May 31; 353(2):269-78. PubMed ID: 25740898
    [Abstract] [Full Text] [Related]

  • 15. The effect of PGI2 analogue on vascular endothelial function and platelet aggregation in patients with NIDDM.
    Nishimura M, Nozaki O, Nakano H, Tsuchida H, Yamada K.
    J Diabetes Complications; 1995 May 31; 9(4):330-3. PubMed ID: 8573759
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension.
    Miyata M, Ueno Y, Sekine H, Ito O, Sakuma F, Koike H, Nishio S, Nishimaki T, Kasukawa R.
    J Cardiovasc Pharmacol; 1996 Jan 31; 27(1):20-6. PubMed ID: 8656653
    [Abstract] [Full Text] [Related]

  • 17. Reduction of progressive burn injury by a stable prostaglandin I2 analogue, beraprost sodium (Procylin): an experimental study in rats.
    Battal MN, Hata Y, Matsuka K, Ito O, Matsuda H, Yoshida Y, Kawazoe T.
    Burns; 1996 Nov 31; 22(7):531-8. PubMed ID: 8909753
    [Abstract] [Full Text] [Related]

  • 18. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR, Belch JJ, Lowe GD, Barbenel JC, Forbes CD.
    Haemostasis; 1987 Nov 31; 17(3):147-53. PubMed ID: 2440771
    [Abstract] [Full Text] [Related]

  • 19. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
    Kanayama T, Kimura Y, Iseki K, Hayashi Y, Tamao Y, Mizogami S.
    J Pharmacol Exp Ther; 1990 Dec 31; 255(3):1210-7. PubMed ID: 1702154
    [Abstract] [Full Text] [Related]

  • 20. The effect of Beraprost sodium on the survival of subcutaneous transferred jejunum after vascular pedicle interruption in a rat model.
    Alexandrou K, Hata Y, Matsuka K, Ito O, Matsuda H, Furuichi H, Ishizu N.
    J Reconstr Microsurg; 1996 Jan 31; 12(1):39-46. PubMed ID: 8618225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.